Stefanova, Nadia <br/><br/>
Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.  [electronic resource] 

 -  Acta neuropathologica  Jul 2012 
 - 51-65 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0533 
<br/><br/><label>Standard No.: </label>10.1007/s00401-012-0977-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2',3'-Cyclic-Nucleotide Phosphodiesterases--metabolism<br/>Analysis of Variance<br/>Animals<br/>Autophagy--drug effects<br/>Brain--drug effects<br/>Dopamine and cAMP-Regulated Phosphoprotein 32--metabolism<br/>Exploratory Behavior--drug effects<br/>Humans<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Transgenic<br/>Microscopy, Immunoelectron<br/>Motor Activity--drug effects<br/>Myelin Proteolipid Protein--genetics<br/>Neurodegenerative Diseases--chemically induced<br/>Oligodendroglia--drug effects<br/>Oligopeptides--toxicity<br/>Proteasome Endopeptidase Complex--metabolism<br/>Time Factors<br/>Tyrosine 3-Monooxygenase<br/>Ubiquitin--metabolism<br/>alpha-Synuclein--genetics